Z
7.32
-0.17 (-2.27%)
| 前收盘价格 | 7.49 |
| 收盘价格 | 7.63 |
| 成交量 | 398,558 |
| 平均成交量 (3个月) | 431,388 |
| 市值 | 396,128,384 |
| 价格/销量 (P/S) | 14.66 |
| 股市价格/股市净资产 (P/B) | 10.21 |
| 52周波幅 | |
| 利润日期 | 5 May 2025 - 9 May 2025 |
| 营业利益率 (TTM) | -128.01% |
| 稀释每股收益 (EPS TTM) | -2.28 |
| 季度收入增长率 (YOY) | -6.80% |
| 总债务/股东权益 (D/E MRQ) | 152.01% |
| 流动比率 (MRQ) | 2.53 |
| 营业现金流 (OCF TTM) | -69.67 M |
| 杠杆自由现金流 (LFCF TTM) | -36.36 M |
| 资产报酬率 (ROA TTM) | -31.03% |
| 股东权益报酬率 (ROE TTM) | -207.84% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Zevra Therapeutics, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
1.3
| 分析师共识 | 5.0 |
| 内部交易活动 | 3.0 |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -3.5 |
| 平均 | 1.30 |
|
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 6.85% |
| 机构持股比例 | 62.99% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Retirement Planning Co Of New England, Inc. | 31 Dec 2024 | 514,832 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 25.00 (Canaccord Genuity, 241.53%) | 购买 |
| 25.00 (Cantor Fitzgerald, 241.53%) | 购买 | |
| 中 | 22.00 (200.55%) | |
| 低 | 18.00 (Citizens Capital Markets, 145.90%) | 购买 |
| 平均值 | 22.00 (200.55%) | |
| 总计 | 5 购买 | |
| 平均价格@调整类型 | 7.93 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Canaccord Genuity | 13 Mar 2025 | 25.00 (241.53%) | 购买 | 7.94 |
| Guggenheim | 13 Mar 2025 | 22.00 (200.55%) | 购买 | 7.94 |
| HC Wainwright & Co. | 13 Mar 2025 | 20.00 (173.22%) | 购买 | 7.94 |
| Cantor Fitzgerald | 12 Mar 2025 | 25.00 (241.53%) | 购买 | 7.92 |
| Citizens Capital Markets | 12 Mar 2025 | 18.00 (145.90%) | 购买 | 7.92 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合